Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness.

Mol Ther Oncol · 2024 · PMC11268112 · PMID 39050989

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The result showed a trend of higher percentage of residual CD19 antigen-negative NALM-6 cells in lower E:T ratios without any difference among CAR structures ( Figure S1 D).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.